Reports for ALLERGAN INC

Company Name

ALLERGAN INC

Totals

Shortage reports

50

Actual shortage: 6 (12%)
Anticipated shortage: 2 (4%)
Avoided shortage: 0 (0%)
Resolved: 42 (84%)

Discontinuation Reports

3

To be discontinued: 0 (0%)
Discontinued: 3 (100%)
Reversed: 0 (0%)

Late reports

7 (13%)

Overdue reports

1 (13%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TAZORAC 0.1% GEL Resolved 2018-11-02 2018-12-01 66125
TAZORAC 0.05% CREAM Resolved 2018-11-02 2018-12-01 66116
TAZORAC 0.05% CREAM Actual shortage 2019-09-16 2019-09-17 93944
TAZORAC 0.1% CREAM Actual shortage 2019-09-16 2019-09-17 93947
VIIBRYD 10MG TABLET Resolved 2019-01-15 2019-02-28 72344
VIIBRYD 10MG TABLET Resolved 2019-02-28 2019-05-14 77159
VIIBRYD 20MG TABLET Resolved 2019-01-15 2019-05-09 72342
VIIBRYD 20MG TABLET Resolved 2019-05-25 2019-06-07 84782
ZYMAR 0.3% SOLUTION Resolved 2017-08-03 2017-10-13 18241
ZYMAR 0.3% SOLUTION Resolved 2017-12-18 2019-09-19 33440

Showing 41 to 50 of 50

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALOCRIL 2% LIQUID Discontinued 2018-11-28 2019-04-02 67803
BETAGAN OPH SOLN 0.25% 0.25% LIQUID Discontinued 2017-08-04 2017-08-04 18275
BLEPHAMIDE S.O.P. 0.2% 10% OINTMENT Discontinued 2019-07-31 2019-07-31 90343